As per the press communiqué AkerBioMarine is said to use the grant to continue its ambitious documentation program on Superba™ Krill products. Aker BioMarine was one of five receivers out of an application pool of 37 companies. It is informed that the research grant allows the company to further intensify our ambitious pre-clinical and clinical research on Superba™ Krill.
Dr. Hogne Vik, Aker BioMarine’s EVP of Documentation, opined that they have been extremely pleased with the results we have seen in our research so far, and this grant contributes to even better documentation for Superba™ Krill – one of very few dietary supplements that is supported by product-specific scientific documentation.
The Research Council of Norway identifies research needs and recommends national priorities in Norway. Aker BioMarine received funds from the User-driven Innovation Projects (BIP), which is targeted at companies with excellent and ambitious research programs. Hallvard Muri, Aker BioMarine’s President and CEO, said that the company feels proud that the Research Council of Norway has granted us a substantial amount of research funding.
He further said that it is a major recognition of Aker BioMarine as a company, Superba™ Krill as a product, and our excellent team of scientists and researchers. Ultimately, it enables Aker BioMarine and our customers to provide more and better information about the benefits of Superba™ Krill to health-conscious consumers.
